• EpiCenter

    The Early Psychosis Intervention Center (“EPICenter”) is the only five-year program in the nation for young people in the early stages of serious mental illness.

  • slide 2

    Introducing our students to the mental health challenges of underserved populations is part of our core mission.

  • APAL slider

    Our AZ Perinatal Psychiatry Access Line provides case consults for providers treating pregnant & perinatal women with mental health and/or substance use disorders.

  • Research

    We are dedicated to foundational and translational research, to conveying skills and clinical knowledge to trainees, and to bringing our expertise to bear where it benefits patients who ask for our help.

  • CIPN

    Patients with difficult-to-treat depression can received specialized treatment, such as ECT, rTMS, and Esketamine, from our Center for Interventional Psychiatry and Neurotherapeutics.

Message from Dr. Karp

Message from Dr. Karp

We are living in extraordinary times in which leaders in psychiatric medicine are needed more than ever. The COVID-19 pandemic, the imperative to fight racism and make our world more equitable, and for all to have access to personalized healthcare requires creative, well-trained psychiatrist leaders to help improve the world through clinical care, education, and research.

read more

The Department of Psychiatry leads efforts to comprehensively prevent and treat psychiatric disorders, conduct cutting-edge research, and prepare future clinicians through rigorous, experiential education. Our commitment to social justice and anti-racism focuses our dedication to serving Southern Arizona’s diverse patient populations.

Events

Behavioral Sleep Medicine Seminar: The Mouth After Midnight
Thursday, April 18, 2024 - 9:00am

News

Drs Esque and Kalia, co-directors of the AZ Pediatric Psychiatry Access Line.
New Pediatric Psychiatry Access Line can help health care providers treat children with mental health disorders

UArizona Health Sciences features Saira Kalia, MD and Jacque Esque, MD, about the Az Pediatric Psychiatry Access Line.


Rohit Madan, MD
Augmentation Strategies for Treatment-Resistant Depression

Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Assistant Professor Rohit Madan shares his research on this subject.